Last updated on November 2019

Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer

Brief description of study

The objective of this study is to establish the performance characteristics of an assay that detects the recurrence of bladder cancer in patients previously diagnosed with bladder cancer. The study is conducted at locations within and outside of the United States. Testing is performed on urine specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.

Clinical Study Identifier: NCT03125460

Find a site near you

Start Over